Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

The DEA grants a one-year extension on telehealth prescription of addiction medications, kicking resolution on a fraught issue to the second Trump administration.

This advertisement has not loaded yet, but your article continues below. Side hustles, renting forever, bankruptcy. Five Torontonians reveal the realities of the affordability crisis in their ...